Addressing sky-high healthcare costs is a pressing need in our country, but the legislation making its way to the Senate isn't the salve our system needs. The bill, titled the “Lower Drug Costs Now Act,” promises to squash lifesaving pharmaceutical innovation and, ultimately, cost lives as it would discourage investment in undeveloped and underdeveloped drugs.
“H. R. 3, the Lower Drug Costs Now Act of 2019, may share the Trump Administration's first goal of lowering prices, but the threat it poses to continued medical innovation will harm American patients in ways that far outweigh any benefits,” reads a statement from the White House.
Read Full Article »